LMO2 and acute lymphoblastic leukemia: Ectopic expression of SCL through chromosomal translocations or microdeletion or transactivation through abnormal expression of proteins within the haematopoietic regulatory network [15] is observed in ~60% of T-ALL cases of which ~40% also display abnormal LMO2 expression [10, 11].